| Janet Englund | Vaccine and Treatment Evaluation Units (VTEUs): Evaluation of Control Measures Against Diseases Other than AIDS | Group Health Cooperative | $538,696 | 12/12/08 |
| Bonnie Ramsey | Consulting Services | GlaxoSmithKline | $10,000 | 12/11/08 |
| Jessica Pollard | Heterogeneity of CD33 Expression in AML and Its Therapeutic Implications | Saint Baldrick's Foundation | $110,000 | 12/11/08 |
| Philip Morgan | Mechanism of Action of Volatile Anesthetics | National Institute of General Medical Sciences | $1,291 | 12/10/08 |
| Allison Eddy | Effects of Antibody-mediated PAI-1 Inhibition in Mouse Unilateral Ureteral Obstruction | CisThera, Inc. | $25,808 | 12/08/08 |
| Catherine Macpherson | Self-Management of Cancer-Related Fatigue by Adolescents: Pilot Study of an Evidence-Based Educational Resource | Alex's Lemonade Stand Foundation | $19,939 | 12/04/08 |
| Ronald Gibson | DNA Collection for Gene Modifier Studies | Cystic Fibrosis Foundation | $189,917 | 12/03/08 |
| Jared Roach | Quantifying Protein Predictors of Machrophage Responses | National Institute of Allergy and Infectious Diseases | $40,652 | 12/03/08 |
| Julia Bledsoe | FAS Diagnostic and Pervention Network | University of Washington | $6,498 | 12/03/08 |
| Bonnie Ramsey | Consulting Services Agreement | Transave, Inc. | $10,000 | 12/02/08 |
| Russell Saneto | Open-Label Clinical Study to Evaluate the Safety, Tolerability, and Antiepileptic Activity of Ganaxalone in Treatment of Patients Recently Diagnosed with Infantile Spasms | Marinus Pharmaceuticals, Inc | $9,865 | 12/02/08 |
| Janet Eary | Phase III Randomized Study of Imatinib, with or without Bevacizumab, in Patients with Metastatic or Unresectable Gasointestinal Stromal Tumors | Southwest Oncology Group | $280,000 | 12/02/08 |
| Margaret Rosenfeld | Phase 4 Trial of Plumozyme in 3-5 yr olds with CF | Genentech, Inc. | $51,598 | 12/02/08 |
| Janet Englund | A Multicenter, Double-blind, Randomized, Placebo-controlled, Dose-ranging Trial Evaluating the Safety and Efficacy of RI-001 in Medically Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness | ADMA Biologics, Inc. | $175,219 | 12/02/08 |
| Patricia Fechner | Phase 3 Study to Evaluate Leuprolide Acetate in Children with Central Precocious Puberty | Abbott Laboratories | $69,511 | 12/02/08 |
| Laura Richardson | SERT Polymorphisms and Depression Remission under Usual Care Conditions among Adolescents | National Alliance for Research on Schizophrenia and Depression | $50,000 | 12/02/08 |
| Valeria Vasta | Variant Detection in Mitochondrial Disorders by Multiplex Gene Resequencing Technology | Mitochondrial Research Guild | $25,000 | 12/02/08 |
| Margaret Sedensky | Suppression of Mitochondrial Defects | Mitochondrial Research Guild | $25,000 | 12/02/08 |
| Philip Morgan | Mitochondrial Defects Alter Propofol Sensitivity | Mitochondrial Research Guild | $25,000 | 12/02/08 |
| Anne Hing | Genetics of Cleft Lip/Palate: A Multicenter International Consortium | University of Iowa | $25,000 | 12/02/08 |
| Troy Torgerson | A Cell Intrinsic Role for FOXP3 in Human Immune System | US Immunodeficiency Network | $62,500 | 12/02/08 |
| Anne Stevens | Alloimmunity in Autoimmune Disease | Fred Hutchinson Cancer Research Center | $8,346 | 12/02/08 |